secwatch.observer — SEC 8-K summary
======================================

Issuer:     STERIS plc (STE)
CIK:        0001757898
Form:       8-K
Filed at:   2026-08-05T20:33:00+00:00
Accession:  0001628280-26-053412
Event type: earnings
Sentiment:  positive
Materiality: 0.65
Item codes: 2.02, 2.05, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

STERIS Q1 revenue $1.5B (+7%), adj EPS $2.59; announces $55-70M restructuring plan
--------------------------------------------------------------------------------

- Revenue $1.5B (+7% YoY); constant currency organic growth 6%. Adjusted EPS $2.59 vs $2.34 prior year.
- Healthcare segment revenue $1.05B (+8%); AST $297.6M (+6%); Life Sciences $146.7M (+9%).
- Operating cash flow $367.1M (down from $420M); free cash flow $279.6M (down from $326.5M).
- Restructuring: consolidation of chemistries to NC Center of Excellence; closure of St. Louis and Plymouth facilities; pre-tax charges $55-70M, completion by fiscal 2030.
- FY2027 guidance reaffirmed: revenue growth 7-8%, adj EPS $11.10-$11.30; CapEx raised to ~$450M, FCF now ~$800M.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1757898/000162828026053412/0001628280-26-053412-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1757898/000162828026053412/ste-20260805.htm
  HTML page:      https://secwatch.observer/filing/0001628280-26-053412

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer